Orshe

Some 16 people are expected to enroll in Medicaid due to health-care overhaul legislation.

Read the rest here: New Medicaid Enrollees Likely to Be Healthier Than Current Ones: Study

Also: 50 million Americans on Medicaid; two studies boost Plavix rivals; pediatricians say no erectile dysfunction drug ads before 10pm.

See more here: A.M. Vitals: Genzyme Rejects Takeover Offer From Sanofi-Aventis

Also: experimental melanoma drug results; California insurance news; radiation at Walter Reed.

Here is the original post:  A.M. Vitals: Judge Won’t Nix Generic Version of Sanofi’s Lovenox

Also: Hepatitis E vaccine study; new self-referral rule for medical imaging; NAIC and HHS on medical-loss ratio.

Original post:  A.M. Vitals: Federal Medical Privacy Rules Go Back for Do-Over

Also: Will accountable care organizations save money?; pharma lobbyists may have to face Republican Congress; research shows disparities in girls’ BMI rates.

View original post here:  A.M. Vitals: FDA Approves Ella, a Longer-Acting ‘Morning-After’ Pill

In addition to J&J’s bonds: regulators struggle with limited-benefit plans; FDA warns on GSK drug; a weight-loss drug trial.

Continued here: A.M. Vitals: J&J Sets Record With Corporate Bond Rates

Also: state regulators look like David to the health insurance industry’s Goliath; two steps forward in regenerative medicine; how Medicare Advantage cuts may play out.

Original post: A.M. Vitals: Omnicare’s Candid Earnings Call

There are some big assumptions behind the new forecast.

See the rest here:  Trustees Say* Medicare Fund Will Now Run Out in 2029 (*With Caveats)

A CMS analysis says it will; the Medicare trustees weigh in later this week.

See more here:  Will Health-Care Overhaul Keep Medicare Solvent Until 2029?

The Mass. ban on gifts to doctors will stand, says a consumer advocacy group.

Go here to see the original:  Follow-Up: Massachusetts Gift Ban Won’t Be Repealed